PTEN and melanoma: In an interesting study performed by Dankort et al., the authors demonstrated that compared to BRAFV600E mice, which developed melanocyte hyperplasia, BRAFV600E/PTENNull mice developed metastatic melanomas, suggesting that PTEN loss collaborates with the BRAFV600E mutation to induce metastasis [43].